vs
维珍大西洋航空(ATLN)与RIGEL PHARMACEUTICALS INC(RIGL)财务数据对比。点击上方公司名可切换其他公司
维珍大西洋航空的季度营收约是RIGEL PHARMACEUTICALS INC的1.7倍($120.0M vs $69.8M),RIGEL PHARMACEUTICALS INC净利率更高(384.0% vs -22.6%,领先406.7%),RIGEL PHARMACEUTICALS INC同比增速更快(21.2% vs -7.3%),过去两年RIGEL PHARMACEUTICALS INC的营收复合增速更高(53.7% vs 9.2%)
维珍大西洋航空(简称维珍航空)是英国知名航空公司,总部位于英格兰西萨塞克斯郡克劳利。该公司成立于1984年,最初名为不列颠大西洋航空,创始人原本计划开通伦敦至福克兰群岛的航线,更名后创始人之一将股份售予理查德·布兰森,如今是英国航空市场的核心运营商之一。
Rigel制药是一家临床阶段生物技术企业,专注于研发及商业化针对自身免疫性疾病、炎症性疾病与血液疾病的靶向小分子疗法,核心市场位于美国,旗下已获批产品可治疗成人免疫性血小板减少症,致力于满足未被覆盖的临床医疗需求。
ATLN vs RIGL — 直观对比
营收规模更大
ATLN
是对方的1.7倍
$69.8M
营收增速更快
RIGL
高出28.5%
-7.3%
净利率更高
RIGL
高出406.7%
-22.6%
两年增速更快
RIGL
近两年复合增速
9.2%
损益表 — Q4 FY2025 vs Q4 FY2025
| 指标 | ||
|---|---|---|
| 营收 | $120.0M | $69.8M |
| 净利润 | $-27.1M | $268.1M |
| 毛利率 | 9.1% | 91.5% |
| 营业利润率 | -19.5% | 33.2% |
| 净利率 | -22.6% | 384.0% |
| 营收同比 | -7.3% | 21.2% |
| 净利润同比 | 60.5% | 1769.2% |
| 每股收益(稀释后) | $-0.48 | $14.11 |
绿色 = 该指标领先。财年不对齐时期间可能不同
8季度营收与利润趋势
并排季度历史对比,按日历期对齐,财年错位的公司也能正确匹配
营收
ATLN
RIGL
| Q4 25 | $120.0M | $69.8M | ||
| Q3 25 | $110.1M | $69.5M | ||
| Q2 25 | $102.9M | $101.7M | ||
| Q1 25 | $102.8M | $53.3M | ||
| Q4 24 | $129.5M | $57.6M | ||
| Q3 24 | $107.8M | $55.3M | ||
| Q2 24 | $104.6M | $36.8M | ||
| Q1 24 | $100.6M | $29.5M |
净利润
ATLN
RIGL
| Q4 25 | $-27.1M | $268.1M | ||
| Q3 25 | $-10.8M | $27.9M | ||
| Q2 25 | $-10.7M | $59.6M | ||
| Q1 25 | $-10.7M | $11.4M | ||
| Q4 24 | $-68.7M | $14.3M | ||
| Q3 24 | $-7.0M | $12.4M | ||
| Q2 24 | $-54.9M | $-1.0M | ||
| Q1 24 | $-4.9M | $-8.2M |
毛利率
ATLN
RIGL
| Q4 25 | 9.1% | 91.5% | ||
| Q3 25 | 11.3% | 93.2% | ||
| Q2 25 | 11.1% | 95.6% | ||
| Q1 25 | 10.9% | 91.7% | ||
| Q4 24 | 10.3% | 89.9% | ||
| Q3 24 | 11.0% | 85.5% | ||
| Q2 24 | 11.0% | 92.4% | ||
| Q1 24 | 10.4% | 93.1% |
营业利润率
ATLN
RIGL
| Q4 25 | -19.5% | 33.2% | ||
| Q3 25 | -7.9% | 40.9% | ||
| Q2 25 | -8.4% | 60.1% | ||
| Q1 25 | -9.2% | 23.9% | ||
| Q4 24 | -4.5% | 28.9% | ||
| Q3 24 | -6.0% | 25.4% | ||
| Q2 24 | -7.9% | 1.2% | ||
| Q1 24 | -1.1% | -23.6% |
净利率
ATLN
RIGL
| Q4 25 | -22.6% | 384.0% | ||
| Q3 25 | -9.8% | 40.2% | ||
| Q2 25 | -10.4% | 58.6% | ||
| Q1 25 | -10.5% | 21.5% | ||
| Q4 24 | -53.0% | 24.9% | ||
| Q3 24 | -6.5% | 22.5% | ||
| Q2 24 | -52.5% | -2.8% | ||
| Q1 24 | -4.8% | -27.9% |
每股收益(稀释后)
ATLN
RIGL
| Q4 25 | $-0.48 | $14.11 | ||
| Q3 25 | $-0.20 | $1.46 | ||
| Q2 25 | $-0.20 | $3.28 | ||
| Q1 25 | $-0.20 | $0.63 | ||
| Q4 24 | $-1.37 | $0.82 | ||
| Q3 24 | $-0.16 | $0.70 | ||
| Q2 24 | $-1.96 | $-0.06 | ||
| Q1 24 | $-0.19 | $-0.47 |
资产负债表与财务实力
最新季度各公司的流动性、杠杆与账面价值一览
| 指标 | ||
|---|---|---|
| 现金及短期投资手头流动性 | $81.1K | $155.0M |
| 总债务越低越好 | $84.7M | $52.5M |
| 股东权益账面价值 | $-32.1M | $391.5M |
| 总资产 | $113.2M | $513.6M |
| 负债/权益比越低杠杆越低 | — | 0.13× |
8季度趋势,按日历期对齐
现金及短期投资
ATLN
RIGL
| Q4 25 | $81.1K | $155.0M | ||
| Q3 25 | $83.4K | $137.1M | ||
| Q2 25 | $374.7K | $108.4M | ||
| Q1 25 | $1.5M | $77.1M | ||
| Q4 24 | $678.7K | $77.3M | ||
| Q3 24 | $1.4M | $61.1M | ||
| Q2 24 | $439.5K | $49.1M | ||
| Q1 24 | $1.7M | $49.5M |
总债务
ATLN
RIGL
| Q4 25 | $84.7M | $52.5M | ||
| Q3 25 | $76.4M | $60.0M | ||
| Q2 25 | $75.4M | $60.0M | ||
| Q1 25 | $66.9M | $60.0M | ||
| Q4 24 | $80.6M | $60.0M | ||
| Q3 24 | $80.8M | $60.0M | ||
| Q2 24 | $78.5M | $60.0M | ||
| Q1 24 | — | $60.0M |
股东权益
ATLN
RIGL
| Q4 25 | $-32.1M | $391.5M | ||
| Q3 25 | $-22.1M | $117.6M | ||
| Q2 25 | $-18.5M | $81.9M | ||
| Q1 25 | $-14.0M | $18.6M | ||
| Q4 24 | $-12.0M | $3.3M | ||
| Q3 24 | $16.2M | $-14.6M | ||
| Q2 24 | $23.0M | $-29.9M | ||
| Q1 24 | $16.8M | $-31.7M |
总资产
ATLN
RIGL
| Q4 25 | $113.2M | $513.6M | ||
| Q3 25 | $110.3M | $242.5M | ||
| Q2 25 | $106.8M | $206.7M | ||
| Q1 25 | $106.5M | $176.0M | ||
| Q4 24 | $119.8M | $164.0M | ||
| Q3 24 | $135.6M | $139.4M | ||
| Q2 24 | $134.2M | $128.4M | ||
| Q1 24 | $3.4M | $126.5M |
负债/权益比
ATLN
RIGL
| Q4 25 | — | 0.13× | ||
| Q3 25 | — | 0.51× | ||
| Q2 25 | — | 0.73× | ||
| Q1 25 | — | 3.23× | ||
| Q4 24 | — | 18.25× | ||
| Q3 24 | 4.98× | — | ||
| Q2 24 | 3.41× | — | ||
| Q1 24 | — | — |
现金流与资本效率
扣除再投资后实际产生的现金。现金流比净利润更难造假
| 指标 | ||
|---|---|---|
| 经营现金流最新季度 | $-8.2M | $22.0M |
| 自由现金流经营现金流 - 资本支出 | $-8.2M | — |
| 自由现金流率自由现金流/营收 | -6.8% | — |
| 资本支出强度资本支出/营收 | 0.0% | — |
| 现金转化率经营现金流/净利润 | — | 0.08× |
| 过去12个月自由现金流最近4个季度 | $-4.5M | — |
8季度趋势,按日历期对齐
经营现金流
ATLN
RIGL
| Q4 25 | $-8.2M | $22.0M | ||
| Q3 25 | $-1.3M | $24.0M | ||
| Q2 25 | $-9.5M | $30.5M | ||
| Q1 25 | $14.6M | $-893.0K | ||
| Q4 24 | $-426.3K | $14.5M | ||
| Q3 24 | $-1.3M | $21.7M | ||
| Q2 24 | $-15.5M | $302.0K | ||
| Q1 24 | $11.2M | $-5.0M |
自由现金流
ATLN
RIGL
| Q4 25 | $-8.2M | — | ||
| Q3 25 | $-1.3M | — | ||
| Q2 25 | $-9.5M | — | ||
| Q1 25 | $14.6M | — | ||
| Q4 24 | $-449.4K | — | ||
| Q3 24 | $-1.4M | — | ||
| Q2 24 | $-15.5M | — | ||
| Q1 24 | $11.2M | — |
自由现金流率
ATLN
RIGL
| Q4 25 | -6.8% | — | ||
| Q3 25 | -1.2% | — | ||
| Q2 25 | -9.3% | — | ||
| Q1 25 | 14.2% | — | ||
| Q4 24 | -0.3% | — | ||
| Q3 24 | -1.3% | — | ||
| Q2 24 | -14.8% | — | ||
| Q1 24 | 11.2% | — |
资本支出强度
ATLN
RIGL
| Q4 25 | 0.0% | — | ||
| Q3 25 | 0.0% | — | ||
| Q2 25 | 0.0% | — | ||
| Q1 25 | 0.0% | — | ||
| Q4 24 | 0.0% | — | ||
| Q3 24 | 0.0% | — | ||
| Q2 24 | 0.0% | — | ||
| Q1 24 | 0.0% | — |
现金转化率
ATLN
RIGL
| Q4 25 | — | 0.08× | ||
| Q3 25 | — | 0.86× | ||
| Q2 25 | — | 0.51× | ||
| Q1 25 | — | -0.08× | ||
| Q4 24 | — | 1.01× | ||
| Q3 24 | — | 1.75× | ||
| Q2 24 | — | — | ||
| Q1 24 | — | — |
财务流量对比
营收 → 毛利润 → 营业利润 → 净利润流向图